218 related articles for article (PubMed ID: 15587927)
21. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
[TBL] [Abstract][Full Text] [Related]
22. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid.
Rogers TL; Nelsen AC; Hu J; Brown JN; Sarkari M; Young TJ; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2002 Nov; 54(3):271-80. PubMed ID: 12445556
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
[TBL] [Abstract][Full Text] [Related]
24. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
25. Enhanced drug dissolution using evaporative precipitation into aqueous solution.
Sarkari M; Brown J; Chen X; Swinnea S; Williams RO; Johnston KP
Int J Pharm; 2002 Aug; 243(1-2):17-31. PubMed ID: 12176292
[TBL] [Abstract][Full Text] [Related]
26. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
27. Nanosizing of poorly water soluble compounds using rotation/revolution mixer.
Takatsuka T; Endo T; Jianguo Y; Yuminoki K; Hashimoto N
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1061-7. PubMed ID: 19801859
[TBL] [Abstract][Full Text] [Related]
28. Transformation of acidic poorly water soluble drugs into ionic liquids.
Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
[TBL] [Abstract][Full Text] [Related]
29. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
30. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants.
Zhang JY; Shen ZG; Zhong J; Hu TT; Chen JF; Ma ZQ; Yun J
Int J Pharm; 2006 Oct; 323(1-2):153-60. PubMed ID: 16828244
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
32. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
33. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
[TBL] [Abstract][Full Text] [Related]
34. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Deng Z; Xu S; Li S
Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
[TBL] [Abstract][Full Text] [Related]
35. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension.
Kakran M; Sahoo NG; Li L; Judeh Z; Wang Y; Chong K; Loh L
Int J Pharm; 2010 Jan; 383(1-2):285-92. PubMed ID: 19781606
[TBL] [Abstract][Full Text] [Related]
36. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
[TBL] [Abstract][Full Text] [Related]
37. Micronization and microencapsulation of felodipine by supercritical carbon dioxide.
Chiou AH; Cheng HC; Wang DP
J Microencapsul; 2006 May; 23(3):265-76. PubMed ID: 16801239
[TBL] [Abstract][Full Text] [Related]
38. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
Peltonen L; Hirvonen J
Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
[TBL] [Abstract][Full Text] [Related]
39. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
40. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
Dalvadi H; Parmar K; Yadav S
Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]